how often to take glp 1 oral solution Long Semaglutide for Weight Loss how often do i take

doi:10.1210/clinem/dgad762

Similar to the DCCT/EDIC, after 10 years of observational follow-up, those originally randomized to intensive glycemic control had significant long-term reductions in MI (15% with sulfonylurea or insulin as initial pharmacotherapy, 33% with metformin as initial pharmacotherapy) and all-cause mortality (13% and 27%, respectively) ACCORD, ADVANCE, and VADT suggested no significant reduction in CVD outcomes with intensive glycemic control in participants followed for shorter durations (3.55.6 years) and who had more advanced type 2 diabetes than UKPDS participants

Recent advances in the development of polyethylenimine-based gene vectors for safe and efficient gene delivery

PMID: 23845922